Neonatal Cardiac Surgery
High Volume, Complex Cases, Superior Outcomes
Our littlest patients receive expert care from cardiac surgeons who are extraordinarily skilled at repairing a range of complex CHD abnormalities including transposition of the great arteries, hypoplastic left heart syndrome, tetralogy of Fallot, total anomalous pulmonary venous connection, and truncus arteriosus.
Arterial Switch Operation
NewYork-Presbyterian has performed more than 400 arterial switch procedures since 1990.
NewYork-Presbyterian's pediatric heart surgeons in the Congenital Heart Center pioneered the innovative arterial switch procedure for infants born with transposition of the great arteries. The procedure was perfected during the 1980s and 1990s by now retired Dr. Jan Quaegebeur, a cardiothoracic surgeon at NewYork-Presbyterian and one of the nation’s top pediatric heart surgeons. The arterial switch procedure corrects dextro-transposition of the great arteries, a condition in which anatomical positions of the pulmonary artery and the aorta are switched so that the aorta rises from the right ventricle and the pulmonary artery arises from the left ventricle. We have performed more than 400 arterial switch procedures since 1990, and our surgeons have been at the forefront of a series of evolutionary operations.
NewYork-Presbyterian performed 68 Norwood procedures from 2016 to 2020 with a 4-year survival rate of 90.5%, which is among the best in the country.
NewYork-Presbyterian pediatric cardiac surgeons have decades of experience performing the Norwood procedure and staged palliation for hypoplastic left heart syndrome (HLHS), with outcomes among the very best in the country. HLHS is a rare CHD in which the left side of the heart is severely underdeveloped and may affect functioning of the left ventricle, aorta, aortic valve, or mitral valve. The Norwood procedure is the first of a 3-step serial procedure to create normal blood flow in and out of the heart, extending the life of infants born with HLHS. It is typically performed in the first 10 days of life. The procedure has the highest risk-adjusted mortality rate among all neonatal and pediatric heart surgeries and is considered the most complex of all the single-ventricle treatment surgeries. NewYork-Presbyterian performed 68 Norwood procedures from July 2016 to June 2020 with a 4-year operative survival rate of 90.5%, compared to a national STS benchmark of 86.4%.